文献速递心血管MR

ST段抬高型心肌梗死早期美托洛尔对左心室应变的影响:METOCARD-CNIC试验的特征追踪心脏磁共振亚研究

Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-09-12

基于METOCARD-CNIC试验的197例急性前壁STEMI患者(100例直接PCI前静脉美托洛尔、97例对照),用特征追踪CMR测量1周和6个月左室整体环周应变(GCS)和整体纵向应变(GLS)。早期静脉美托洛尔组1周时GCS和GLS均较对照组更保留,两组随访期间应变均显著改善。

要点

  • STEMI后1周,早期静脉美托洛尔组GCS较对照组更保留(-13.9±3.8% vs -12.6±3.9%,p=0.013)。
  • STEMI后1周,早期静脉美托洛尔组GLS较对照组更保留(-11.9±2.8% vs -10.9±3.2%,p=0.032)。
  • 按GCS和GLS四分位分组,1周和6个月时第一四分位(左室收缩功能最差)中接受早期静脉美托洛尔者显著少于对照组(两个时间点GCS和GLS均p<0.05)。

核心结论

  • 在前壁STEMI患者中,直接PCI前早期静脉给予美托洛尔与1周和6个月时左室GCS和GLS严重减低患者数显著更少相关;特征追踪CMR可作为评估心脏保护治疗获益的补充工具。

研究设计与样本

  • METOCARD-CNIC试验的特征追踪CMR亚研究,共197例急性前壁STEMI患者,其中100例随机分配至直接PCI前静脉美托洛尔、97例为对照。

诊断标准与关键数值

  • GCS和GLS采用特征追踪CMR于STEMI后1周和6个月测量。
  • 1周时GCS:美托洛尔组-13.9±3.8% vs 对照组-12.6±3.9%,p=0.013。
  • 1周时GLS:美托洛尔组-11.9±2.8% vs 对照组-10.9±3.2%,p=0.032。
  • 6个月与1周应变平均差值:美托洛尔组GCS -2.9%(95%CI -3.5%至-2.4%)、GLS -2.9%(95%CI -3.4%至-2.4%),均p<0.001;对照组GCS -3.4%(95%CI -3.9%至-2.8%)、GLS -3.4%(95%CI -3.9%至-3.0%),均p<0.001。
  • 按GCS和GLS四分位分组,第一四分位(左室收缩功能最差)中接受早期静脉美托洛尔者较对照组显著更少(1周和6个月GCS、GLS均p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to evaluate the effect of early intravenous metoprolol on left ventricular (LV) strain assessed with feature-tracking cardiovascular magnetic resonance (CMR).

BACKGROUND: Early intravenous metoprolol before primary percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) portends better outcomes in the METOCARD-CNIC (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) trial.

METHODS: A total of 197 patients with acute anterior STEMI who were enrolled in the METOCARD-CNIC trial (100 allocated to intravenous metoprolol before primary PCI and 97 control patients) were evaluated. LV global circumferential strain (GCS) and global longitudinal strain (GLS) were measured with feature-tracking CMR at 1 week and 6 months after STEMI and compared between randomization groups.

RESULTS: Patients who received early intravenous metoprolol had significantly more preserved LV strain compared with the control patients at 1 week after STEMI (GCS -13.9 ± 3.8% vs. -12.6 ± 3.9%, respectively; p = 0.013; GLS -11.9 ± 2.8% vs. -10.9 ± 3.2%, respectively; p = 0.032). In both groups, LV strain significantly improved during follow-up (mean difference between 6-month and 1-week strain for the metoprolol group: GCS -2.9%, 95% confidence interval [CI]: -3.5% to -2.4%; GLS: -2.9%, 95% CI: -3.4% to -2.4%; both p < 0.001; the control group: GCS -3.4%, 95% CI: -3.9% to -2.8%; GLS -3.4%, 95% CI: -3.9% to -3.0%; both p < 0.001). When dividing the overall cohort of patients in quartiles of GCS and GLS, there were significantly fewer patients in the first quartile (i.e., the worst LV systolic function) who received early intravenous metoprolol compared with control patients at 1 week and 6 months (p < 0.05 for GCS and GLS at both time points).

CONCLUSIONS: In patients with anterior STEMI, early administration of intravenous metoprolol before primary PCI was associated with significantly fewer patients with severely depressed LV GCS and GLS, both at 1 week and 6 months. Feature-tracking CMR represents a complementary tool to evaluate the benefits of cardioprotective therapies. (Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion [METOCARD-CNIC]: NCT01311700).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Podlesnikar T, Pizarro G, Fernández-Jiménez R, et al. Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial. JACC Cardiovasc Imaging. 2018. PMID: 30219400. doi:10.1016/j.jcmg.2018.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。